BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 16207846)

  • 1. Genetic modifiers of lung disease in cystic fibrosis.
    Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
    N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
    Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
    Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
    Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
    J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.
    Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
    Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
    Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
    Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
    Geborek A; Hjelte L
    J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
    de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
    Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
    Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
    Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene modifiers of lung disease.
    Knowles MR
    Curr Opin Pulm Med; 2006 Nov; 12(6):416-21. PubMed ID: 17053491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
    Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
    N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Preumont V; Hermans MP; Lebecque P; Buysschaert M
    Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission ratio distortion and maternal effects confound the analysis of modulators of cystic fibrosis disease severity on 19q13.
    Becker T; Jansen S; Tamm S; Wienker TF; Tümmler B; Stanke F
    Eur J Hum Genet; 2007 Jul; 15(7):774-8. PubMed ID: 17406643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
    Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
    Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.
    Fajac I; Hubert D; Guillemot D; Honoré I; Bienvenu T; Volter F; Dall'Ava-Santucci J; Dusser DJ
    Thorax; 2004 Nov; 59(11):971-6. PubMed ID: 15516474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.